NCT03215381View on ClinicalTrials.gov

AZD1390 Administration of a Microdose [11C]AZD1390 to Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 10, 2017

Primary Completion Date

February 19, 2018

Study Completion Date

February 19, 2018

Conditions
Healthy Volunteer Male Subjects
Interventions
DRUG

[11C]AZD1390

\[11C\]AZD1390

Trial Locations (1)

171 76

Research Site, Stockholm

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
collaborator

Karolinska Institutet, Quintiles IMS

UNKNOWN

lead

AstraZeneca

INDUSTRY